Moran Kyle's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Feb 11, 2026
- Accession no.
- 0001193125-26-047323
- Filed
- Feb 11, 2026
- Trade date
- Feb 5-9, 2026
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $48.3K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moran KyleCIK 0001657765 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Ordinary Shares | AGrant or awardAcquired | +45,625 | $0.00 | $0 | 137,973 | Direct | |
| Feb 9, 2026 | Ordinary Shares | SSaleDisposed | −3,588 | $13.45 | −$48,258.6 | 134,385 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Ordinary Shares | AGrant or awardAcquired | +273,750 | $0.00 | $0 | 273,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.